Medical Device IPOs: Year of the Comeback?

September 1, 2004

4 Min Read
Medical Device IPOs: Year of the Comeback?

Originally Published MX September/October 2004

BUSINESS NEWS

After a complete absence from the public equity markets in 2003, the medtech industry is showing signs that the initial public offering (IPO) may be reemerging as a viable tool for capital formation. Renaissance Capital (Greenwich, CT) reports that six medtech companies issued IPOs during the first six months of this year (see Table I).

Company

Location

Ticker

Web Site

Products

2003 Revenues
($ millions)

Employees
(no.)

AngioDynamics Inc.

Queensbury, NY

NASDAQ:
ANGO

www.angiodynamics.com

Medical devices used in minimally invasive, image-guided procedures to treat peripheral vascualr disease.

46.2

218

Animas Corp.

West Chester, PA

NASDAQ:
PUMP

www.animascorp.com

External insulin pumps.

31.6

290

Cutera Inc.

Brisbane, CA

NASDAQ:
CUTR

www.cutera.com

Laser-based products for aesthetic removal of hair, wrinkles, and leg and facial veins.

44.1

112

Digirad Corp.

Poway, CA

NASDAQ:
DRAD

www.digirad.com

Solid-state medical imaging products for the detection of cardiovascular disease.

59.1

316

Kinetic Concepts Inc.

San Antonio, TX

NYSE:
KCI

www.kci1.com

Advanced wound care and therapeutic surface products.

821.7

4096

NuVasive Inc.

San Diego, CA

NASDAQ:
NUVA

www.nuvasive.com

Surgical products for the treatement of spine disorders.

25.8

83

Table I. Company information for medical device firms placing initial public offerings during the first six months of 2004. Data: Renaissance Capital and company reports.

Continuing the trend since the midpoint of the year, three additional medtech companies have launched their anticipated IPOs. NeuroMetrix Inc. (Waltham, MA) went public on July 22 (NASDAQ: NURO) with an opening price of $8.00, which had risen to $8.08 at the end of August. Syneron Medical Ltd. (Yoqneam, Israel), began trading on August 9 (NASDAQ: ELOS) with an opening price of $12, which fell back slightly to $11.90 at the end of August. Stereotaxis (St. Louis) began trading on August 12 (NASDAQ: STXS) with an opening price of $8, which had risen to $9.14 by the end of the month.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like